Lumexa refinances $825M term loan and $250M revolver; maturities extended to 2032 and 2030

Lumexa Imaging Holdings, Inc.

$825M secured term loan facility (Refinancing Term Loan) priced at SOFR+3% or Prime+2%, maturing December 2032.
$250M secured revolving credit facility (Amended Revolving Credit Facility) at same rates with step-down pricing, maturing December 2030.
Financial covenant requires net leverage ≤7.50x if revolving exposure exceeds 40% of the $250M facility at quarter end.
Proceeds used to repay existing Amendment No. 3 term loans and pay related fees and expenses.
Barclays Bank PLC acts as administrative agent, issuing bank and swing line lender; guarantees from all material subsidiaries remain.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Lumexa Imaging Holdings, Inc. amended Amended Credit Agreement with Barclays Bank PLC valued at $825 million term loan and $250 million revolving credit facility (effective 2025-12-17).

Action: amendment
Agreement: credit facility
Counterparty: Barclays Bank PLC
Value: $825 million term loan and $250 million revolving credit facility
Effective: 2025-12-17

Exact text from the filing

On December 17, 2025, Lumexa Imaging, Inc. and Lumexa Imaging Outpatient, Inc. (collectively, the " Borrowers "), each an indirect wholly-owned subsidiary of Lumexa Imaging Holdings, Inc. (the " Company "), the other Loan Parties party thereto, the Lenders party thereto and Barclays Bank PLC, as administrative agent, an Issuing Bank and the Swing Line Lender, entered into an amendment to their existing Credit Agreement (as so amended, the " Amended Credit Agreement ").

View on SEC.gov

Browse all material agreements →

Lumexa Imaging Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-324774

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.